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We identified a novel 6.33Mb deletion of 1q21.3q23.3 (hg18;
chr1: 153035245–159367106) in two siblings presenting with
blepharophimosis, ptosis, microbrachycephaly, severe psycho-
motor, and intellectual disability. Additional common features
include small corpus callosum, normal birth length and head
circumference, postnatal growth restriction, low anterior hair-
line, upturned nose, bilateral preauricular pits, widely spaced
teeth, gingival hypertrophy, left ventricular dilatation with
decreased biventricular systolic function, delayed bone age,
5th finger clinodactyly, short 3rd digit, hyperconvex nails,
obstructive and central sleep apnea, and bilateral heel contrac-
tures. Fluorescence in situ hybridization (FISH) performed in
the mother of both children showed an apparently balanced,
intrachromosomal insertional translocation of 1q21.3q23.3 to
1q42.12. The sibling recurrence likely arose by a maternal
meiotic crossing over on the rearranged chromosome 1 between
the deleted region and the insertion. We hypothesize that the
decreased cardiac function and contractures may be related to
LMNAhaploinsufficiency. This case illustrates the importance of
FISH when attempting to determine inheritance of a copy-
number variation and emphasize the value of evaluating known
haploinsufficiency phenotypes for genes in deleted regions.
 2012 Wiley Periodicals, Inc.
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INTRODUCTION
The use of array-comparative genomic hybridization (CGH) has
allowed clinicians to detect pathogenic copy number losses and
gains with ever increasing sensitivity. Abnormal results require
further laboratory investigation not only for confirmation pur-
poses, but also to investigate whether the genomic gain or loss
occurred de novo or was the result of a parental chromosomal
abnormality. Fluorescence in situ hybridization (FISH) may pro-
vide critical information about parental balanced insertional trans-
locations or other chromosomal rearrangements that may
otherwise be missed and can impact recurrence risk significantly.
Insertional translocations can be: (a) simple intrachromosomal or
interchromosomal insertional translocations or (b) complex inser-
tional translocations [Kang et al., 2010]. Nowakowska et al. [2011]
found that 2.1% of array abnormalities were the consequence of a
parental balanced insertional translocation. This may be an under-
estimate since not all parents were available for evaluation in their
study and very small array abnormalities were not fully evaluated
given the limitations of FISH. However, this supports the impor-
tance of FISH confirmation when faced with an array abnormality.
There are multiple patients described in the literature with
deletions that include part or all of 1q21-q23 [Estevez de Pablo
et al., 1980; Schinzel and Schmid, 1980; Moghe et al., 1981; Martin
and Simpson, 1982; Taysi et al., 1982; Silengo et al., 1984; Beemer
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et al., 1985; Franco et al., 1991; Leichtman et al., 1993; Lo et al., 1993;
Melis et al., 1998;Waggoner et al., 1999; Pallotta et al., 2001;Monica
et al., 2007; Reddy et al., 2009]. Variable sizes and deletion end-
points on 1q21-q23 give rise to a wide variety of clinical problems.
We present a male propositus and his female sibling with highly
similar features includingblepharophimosis, ptosis, developmental
intellectual disability, postnatal growth restriction, numerous dys-
morphic features, obstructive/central sleep apnea, and seizures.
Initial karyotypes performed prior to the advent of chromosomal
microarrays showed normal G-banded results. Re-evaluation of
these children with chromosomal microarray studies showed a
6.33Mb loss of chromosome 1q21.3q23.3 (hg18; chr1: 153035245
–159367106) in both children, that resulted from the unbalanced
product inherited from a maternal insertional translocation. We
describe the clinical, cytogenetic, and molecular features of these
siblings, and we compare their phenotypes to deletion 1q21-q23
cases in the literature.
MATERIALS AND METHODS
Research was approved by the Institutional Review Board for
Human Subject Research at the University of Michigan. Informed
consent was obtained from the family. Chromosomal microarray
analyses were conducted in the Michigan Medical Genetics Labo-
ratories (MMGL) at the University of Michigan using two
oligonucleotide-based array platforms with whole genome cover-
age: a custom-designed EMArray Cyto6000 chip, implemented on
the Agilent 44K platform [Baldwin et al., 2008], which originally
identified a 6.5Mb deletion, and the Agilent human genome
G4411B 244K array platform (Agilent Technologies Inc., Santa
Clara, CA) to refine the boundaries of the deletion interval to
6.33Mb (the latter is shown in Fig. 2). The procedures for DNA
digestion, labeling, and CGH were as described in Agilent
oligonucleotide-based array CGH for genomic DNA analysis,
Protocol version 4.0 June 2006 (Agilent Technologies, Inc.) with
some modifications [Baldwin et al., 2008]. The fluorescent signals
on the array slides were detected and scanned into image files using
the GenePix 4200A scanner and GenePix-Pro 6.1 software (Axon
Instruments/Molecular Devices Corp., Union City, CA). The array
images were imported and converted for display by Agilent Feature
Extraction 9.5 software. Data were analyzed by Agilent’s CGH
Analytics 3.5 software to determine copynumber variation between
experimental DNA and a sex mismatched control DNA prepara-
tion. Numbering of the Cyto6000 44K EMArray and 244K Agilent
array results utilized the UCSC hg18 (Build 36.1, March 2006)
assembly. The resultant data were extracted using Feature Extrac-
tion software, version 9.5.1.1, and analyzed and plotted using CGH
Analytics version 3.5.14 orDNAanalytics version 4.0.81 (both from
Agilent Technologies) using ADM-1 algorithm with a sensitivity
threshold of 6.7 (for Agilent 244k arrays the settings are ADM-2
algorithmwith a sensitivity threshold of 6.0). Gains and losses were
called according to interpretation criteria established by the Inter-
national Standard Cytogenomic Array (ISCA) Consortium, as
described in Baldwin et al. [2008]. The resulting log 2 derivatives
of the patient:control signal intensity ratios were plotted relative to
the genomic location of the corresponding probes. For detection
of gains or losses the thresholds for the log 2 ratios were set at0.32
for losses and 0.26 for gains. A minimum of four contiguous
oligonucleotide probes showing loss or gain of signal intensity
was required tomake an aberration call. The deletionwas verified in
the patients using BAC probe RP11-101J8 (Bluegnome, Cambridge,
UK) in metaphase FISH. This same probe was used for parental
FISH analysis. To determine the orientation of the insertion in
the maternal chromosome 1, an additional BAC RP11-307C12
probe (Bluegnome), mapping within the deleted region, was used.
Metaphase FISH was performed by standard methods in the
University of Michigan Clinical Cytogenetics Laboratory.
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Patient 1 was the product of an uncomplicated first pregnancy to a
29-year-old woman whose prenatal ultrasounds exams were nor-
mal.Hewas born at 41weeks gestation via cesarean due to failure to
progress. At birth, weight, occipitofrontal head circumference
(OFC), and length were at the 28th, 25th, and 25th centiles,
respectively. Dysmorphic features observed at birth included:
bilateral preauricular pits, low set and small ears which measured
3.0 cm (right; 3.5 SD) and 3.2 cm (left; 3.5 SD), overfolded
helices, wide nasal bridge with an inner canthal distance of 2.5 cm
(þ2 SD), short palpebral fissures of 1.4 cm (3 SD), bulbous nose
withnasal septumextendingbelow thenasal alae, right eyelidptosis,
and retrognathia. Figure 1 shows facial features of Patient 1 at 7, 9,
and 16 years of age. Echocardiogram showed a secundum atrial
septal defect (ASD) and apical muscular ventricular septal defect
(VSD), a dilated left ventricle, and patent ductus arteriosus (PDA),
which was closed by coil occlusion at 17 months of age; ASD and
VSD, closed spontaneously. Bilateral inguinal hernias were surgi-
cally corrected on day of life 2 by herniorrhaphy. A persistent
undescended right testiclewas surgically corrected by orchiopexy at
2 years of age. A gastric feeding tube and Thal fundoplication were
performed at 6months of age.At 16months of age, hisweight,OFC,
and height were 9.9 kg (11th centile), 45 cm (3rd centile), and
70.5 cm (<3rd centile; 50th centile for an 11-month-old), respec-
tively. Exam showed bilateral blepharophimosis and ptosis. At
16 months he began sitting unsupported, pulling to stand briefly
with the assistance of furniture and began rolling over in both
directions. Radiographic evaluation at 16 months showed a bone
age of 1 year; radiographs also showed mild shortening of the
middle phalanges of the 5th fingers, consistent with bilateral
clinodactyly. At 35 months of age he began cruising and following
simple commands but had not developed a pincer grasp.
The patient developed tonic seizures twice at 3.5 years of age.
Brainmagnetic resonance imaging (MRI) indicated the presence of
a small corpus callosum and a small volume brain stem. Brain
computed tomography (CT) showed microcephaly with low-
density white matter. Gray matter irregularities were also noted
with increased gyrations present consistent with possible hetero-
topia and cortical dysplasia. Electroencephalogram (EEG) showed
left frontal central epileptiform activity with mild diffuse neuronal
dysfunction. He was treated for only 1.5 months with the anti-
convulsant Phenytoin (Dilantin), after which it was discontinued.
He subsequently experienced two seizures at 8 years of age with an
EEG showing multifocal spikes and background slowing. He was
treated with the anticonvulsant Levetiracetam (Keppra) from 8 to
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FIG. 1. Facial features ofmale at (A) 7 years of age, (B) 9 years, and (C) 16 years. Facial features of female at (D) 2 years of age, (E) 4 years, and (F) 9
years. Note low anterior hairline, blepharophimosis, low set ears, corpuscular lobules, upturned nose, and thin vermillion border.
FIG. 2. Chromosomal microarray (CMA) results detailing a 6.33 Mb deletion on chromosome 1 q21.3q23.3 (hg18; chr1: 153035245–159367106).
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10 years of age and then weaned off of all anti-epilepticmedication,
with no further seizures to date. He ambulated with assistance at
7 years of age. At 7 years, all growth centiles were <5th centile,
sleep studies showed both obstructive and central apneas, which
improved with oxygen supplementation, and a trial of continuous
positive airway pressure (CPAP) was unsuccessful. Increased tone
was noted in his lower extremities at 8 years.
At 16 years of age he was walking independently and following
simple commands, yet he had no expressive language. His weight,
OFC, and height were 37.9 kg (3 SD), 51.7 cm (<3rd centile;
50th centile for a 4-year-old), and 130 cm (<3rd centile; 50th
centile for 8-year-old), respectively. His ears were normally set
and measure 5.7 cm (left;1 SD) and 5.4 cm (right;1.5 SD). Eye
exam demonstrated an interpupillary distance of 5.5 cm (25th
centile), inner canthal length of 3.2 cm (50th centile), and an outer
canthal distance of 8.0 cm (10th centile). Palpebral fissures meas-
ured 2.4 cm (left;5 SD) and 2.3 cm (right;5 SD).He had slightly
arched eyebrows, a flat philtrum of normal length, a tented upper
lip, widely spaced teeth, and prominent gingival hypertrophy. He
drooled persistently. Extremity exam showed limitation of exten-
sion and supination of his arms bilaterally. His left palm measured
10.5 cm (30th centile) with total hand length of 17.0 cm (15th
centile). His right palmmeasured 10.5 cm (30th centile) with a total
hand length of 17.2 cm (20th centile). Middle finger lengths meas-
ured 6.5 cm (left;<3rd centile,50th centile for 9.5-year-old) and
6.7 cm (right;<3rd centile,50th centile for 10-year-old). Bilateral
2nd toenails and right 5th toenail were hyperconvex. Toes were
short with bilateral distal valgus positioning of the 1st toe. The feet
measured 22.3 cm (left; 3 SD) and 21.5 cm (right; 4 SD). The
patientwalkedwithbothhips andkneesflexed.Hehadbilateral heel
contractures, treated with ankle–foot orthoses, limitation of full
knee extension, and a 37 curvature of the lumbar–thoracic to low
lumbar spine on radiographs.
Recent cardiac evaluation and echocardiography at 17 years of
age showed Patient 1 to have mildly diminished right ventricular
and mild-moderately diminished left ventricular systolic function
with mild dilation of the left ventricle (Z-score þ2.5). Electro-
cardiographic evaluation, includingHoltermonitoring, showed no
conduction abnormalities. Given the decreased systolic function
Patient 1was started onEnalapril (Vasotec) for afterload reduction.
Following the birth of Patient 1 the mother experienced two
spontaneousmiscarriages at 17weeks gestation and between 14 and
15 weeks gestation. Fetal autopsy of the latter showed no major
malformations and the cause of the demise was not identified.
Patient 2 is the younger female sibling of Patient 1. The preg-
nancy was complicated by intrauterine growth restriction and
premature and prolonged rupture of membranes. The patient
was born at 35 weeks gestation via vaginal delivery. Upon delivery,
Apgar scores were 3, 6, and 9 at 1, 5, and 10min, respectively. At
birth, her weight, OFC and length were at the 3rd, 30th, and 5th
centiles, respectively. Figure 1 shows facial features of Patient 2 at 2,
4, and 9 years of age. She remained in the neonatal intensive care
unit for 15 days secondary to preterm delivery and hyperbilirubi-
nemia (maximum of 9.1mg/dl) that was treated successfully with
phototherapy. She was also diagnosed with transient thrombocy-
topenia requiring 1 platelet transfusion. The patient’s growth
centiles progressively fell during infancy. The patient began using
oxygen supplementation between 3 and 4months of age following a
viral infection. Since then, she has continuedwithnighttimeoxygen
via nasal cannulawith sleep studies showing obstructive and central
apneas, which improved on oxygen. Like her brother, a trial of
CPAP was unsuccessful. At 6 months of age she required gastro-
stomy tube placement and Nissen fundoplication due to poor
weight gain and gastroesophageal reflux. She had severe global
developmental delay, sitting at 15 months of age but unable to roll
over. Dysmorphic facial features include microcephaly, prominent
metopic ridge, blepharophimosis, upturned nose, bilaterally over-
folded and thickened helices and high palate. The patient experi-
enced a generalized tonic–clonic seizure at 2 years. EEG at that time
showed left frontal lobe hyperactivity. No other seizures have been
recorded. Brain MRI showed mildly diminutive corpus callosum
and Arnold–Chiari malformation with cerebellar tonsils extending
6–7mm below the foramen magnum. Increased tone was noted in
the lower extremities.
At 11 years of age, she walked independently and followed
simple commands but had no expressive language. Her weight
was 26.4 kg (1st centile) and head circumferencewas 47.6 cm (<3rd
centile, 4 SD). She had not yet entered puberty. She had coarse
golden-brown hair, a low anterior hairline, and preauricular pits
bilaterally. Her ears measured 5.0 cm (left; 2.5 SD) and 4.8 cm
(right; 2.5 SD) and they were normally set. She had blepharo-
phimosis and ptosis. Her interpupillary distance measured 5.4 cm
(50th centile); inner canthal distance was 3.3 cm (þ1 SD); outer
canthal distance was 7.8 cm (1.5 SD) and palpebral fissures
measured 2.2 cm (left; 5 SD) and 2.0 cm (right; 5 SD). She
had anteverted nares, a flattened philtrum, thin upper lip vermil-
lion, gingival hypertrophy, andwidely spaced teeth. Shehadnormal
range of motion of the upper extremities. Her left palm measured
9.0 cm (45th centile) with a total left hand length of 15.2 cm (25th
centile). The right palmmeasured 8.7 cm (35th centile) with a total
right hand length of 15 cm (15th centile). Middle finger lengths
measured 6.2 cm (left; 15th centile) and 6.3 cm (right; 20th centile).
She had hyperconvex 2nd and 5th toenails bilaterally, and bilateral
5thfinger clinodactyly.Her left footmeasured 18.0 cm (4 SD) and
right foot was 19.5 cm (3 SD). She had bilateral heel contractures
treated with ankle–foot orthoses.
At 12 years of age Patient 2 underwent formal cardiology
evaluation. Echocardiography showed mildly diminished right
and left ventricular systolic function as well as a mildly dilated
left ventricle (Z-score þ2.3). Electrocardiogram showed a first
degree atrio-ventricular (AV) block confirmed by Holter monitor-
ing showing aswell an isolated sinus node exit blockwithoccasional
junctional escape. Given the diminished systolic function Patient 2
was placed on Enalapril (Vasotec) for afterload reduction.
RESULTS
Both siblings had normal peripheral blood G-banded karyotypes
and normal subtelomeric FISH analysis. Because Patient 1 had
features similar to blepharophimosis, ptosis, and epicanthus inver-
sus syndrome (BPES; OMIM 110100) we performed FOXL2 DNA
sequencing and FISH for a 3q23 microdeletion at the FOXL2 locus
given that 12% of patients with BPES have a deletion of FOXL2
[Beysen et al., 2009; D’haene et al., 2010]. Both studies were normal
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inPatient 1.Amaternal bloodkaryotype performed in 1997 showed
a probable paracentric inversion 46,XX,inv(1)(q42.11q42.3),
which was not studied further. Combined microarray and FISH
analyses of newmaternal samples obtained because of the discovery
of deletions in her offspring, showed this instead to be an intra-
chromosomal insertional translocation involving chromosome 1.
Both siblings showed a 6.33Mb single copy deletion of 1q21.3q23.3
by chromosomal microarray (CMA; Fig. 2), which was confirmed
by metaphase FISH with BAC probe RP11-101J8 (Fig. 3). Parental
FISH analysis with probe RP11-101J8 showed normal paternal
studies and an insertion of 1q21.2q23.3 material at 1q42.12 on
one maternal chromosome 1 homologue. The insertion was deter-
mined to be direct (same orientation), by FISH using BAC probes
RP11-101J8 and RP11-307C12, which map within the inserted
region. Maternal peripheral blood CMA (Agilent, 244K) was
normal indicating that, at the resolution of the CMA used, the
insertion appears balanced. Figure 3 shows the results of FISH
studies for the mother and Patient 2. These results suggest that the
occurrence of del(1)(q21.3q23.3) in both siblings likely occurred
via recurrent maternal meiotic crossing over between 1q21.3q23.3
and the insertional translocation at 1q42.
DISCUSSION
We describe two siblings with a unique combination of features
associated with a 6.33Mb deletion of 1q21.3q23.3 (hg18; chr1:
153035245–159367106). The major features shared by them
include severe intellectual disability, normal birth length and
head circumference, postnatal growth restriction, microbrachyce-
phaly, blepharophimosis, ptosis, upturned nose, bilateral preaur-
icular pits, widely spaced teeth, gingival hypertrophy, left
ventricular dilatation with decreased biventricular systolic func-
tion, delayed bone age, 5th finger clinodactyly, short 3rd digit, heel
contractures, short feet, and hyperconvex nails. Both patients also
exhibit central and obstructive sleep apnea, requiring oxygen
therapy, and seizures with brain imaging showing a small corpus
callosum.Congenital heart defects (ASD,VSD, andPDA)were seen
only in Patient 1.
The deletions in Patients 1 and 2 resulted from inheritance of a
meiotic recombination product involving amaternal chromosome
carrying an apparently balanced insertion of 6.33Mb of material
from 1q21.3q23.3 inserted into 1q42.12. Maternal meiotic recom-
bination likely occurred between the deletion and insertion sites on
FIG. 3. Chromosome 1 metaphase FISH studies in mother (top) showing normal and insertional translocation chromosomes, and normal and
recombinant chromosome (with deletion) in daughter (bottom). Control chr1 telomeric BAC probe (green telomeric signal), and BAC probes for
1q21.3q23.3 (green and red interstitial signals, RP11-101J8 and RP11-307C12, which allowed for assessment of directionality of the insertion).
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1q in both children, leading to deletion of 1q21.3q23.3 in the two
children. Nowakowska et al. [2011] reported 10 cases with array
abnormalities caused by parental apparently balanced insertional
translocations. In all 10 cases, similar to ours, array-CGH analysis
showedhaploinsufficiency in thepatients,whichwere all confirmed
by FISH analysis although subsequent parental FISH studies deter-
mined that the imbalances were inherited from a parent carrying an
apparently balanced insertion. These cases highlight the need
for FISH analysis of what may appear to be losses or gains detected
by array analysis, especially in cases where family recurrence is
observed.
There have been multiple patients described in the literature
with deletions that include part or all of the 6.33Mb loss in our
patients [Estevez de Pablo et al., 1980; Schinzel, 2001; Moghe et al.,
1981; Martin and Simpson, 1982; Taysi et al., 1982; Silengo et al.,
1984; Beemer et al., 1985; Franco et al., 1991; Leichtman et al., 1993;
Loet al., 1993;Melis et al., 1998;Waggoner et al., 1999;Pallotta et al.,
2001;Monica et al., 2007;Reddyet al., 2009].Wecompiled a table of
clinical features to determine the frequency of abnormalities in
patients with deletions of chromosome 1 overlapping q21.3q23.3
(Table I) in order to determine possible genotype–phenotype
correlations. Common features observed in our two siblings
include blepharophimosis, everted nares, preauricular pits, widely
spaced teeth, low-set ears, gingival hypertrophy, obstructive sleep
apnea, hypoventilation syndrome with the need for supplemental
oxygen at night, hypoplastic corpus callosum, left ventricle dilata-
tion, increased lower extremity tone, feeding difficulty, and seiz-
ures.Arnold–Chiari Type Imalformation, inPatient 2, has not been
reported in other patients with similar deletions, perhaps because
ascertainment was not attempted. The greatest limitation to the
comparisons here are the uncertainties of genomic boundaries in
prior reports. In addition, genotype–phenotype correlation may
not be possible with so few patients, and deletions may disrupt
regulation of adjacent, non-deleted genes.
There are 123 known genes that lie within the 6.33Mb genomic
region and 18 are online Mendelian inheritance in man (OMIM)
disease genes. Table II details the 18 OMIM disease genes, their
clinical characteristics and inheritance. We examined those 18
genes for potential haploinsufficiency phenotypes. Of these 18,
Lamin A/C haploinsufficiency (LMNA) can give rise to the allelic
disorders autosomal dominant Emery–Dreifuss muscular dystro-
phy (EDMD), limb-girdle muscular dystrophy type 1B, and dilated
cardiomyopathy type 1A [Benedetti et al., 2007]. Patientswith these
disorders typically exhibit a combination of symptoms. Bonne et al.
[1999, 2000] reported wide clinical variability for heterozygous loss
of LMNA function, and EDMD patients may also exhibit contrac-
tures of the elbows and the Achilles tendons. Although there are
certainly other potential reasons, we speculate that LMNA loss of
function may be related to the Achilles and elbow contractures in
our patients. We acknowledge in Patient 2 that Arnold–Chiari
malformation should be taken into account with respect to con-
tractures, butArnold–Chiarimalformation is not present inPatient
1. Given that cardiac pathology (cardiac conduction abnormalities
and dilated cardiomyopathy) may arise in patients with LMNA
heterozygous loss of function [Benedetti et al., 2007], we sought
formal cardiac evaluations for Patients 1 and 2. Those evaluations
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ventricular dilation in both and AV conduction abnormalities in
Patient 2. Irrespective ofwhetherhaploinsufficiency forLMNAmay
also explain this cardiac pathology, it was ultimately the review of
the phenotypes causedbyheterozygous losses in the deleted interval
that led to consideration of the potential for cardiac involvement.
Haploinsufficiency for other genes in this interval are likely con-
tributors to abnormal CNS development and function as well as
craniofacial dysmorphisms.
For many years prior to the identification of the deletion in our
patients, our differential diagnosis based on their clinical features
includedBlepharophimosis–ptosis–epicanthus inversus syndrome
(BPES), 17q21 microdeletions, and the blepharophimosis–mental
retardation (BMR) family of syndromes previously known as
Ohdo syndrome [Ohdo et al., 1986; White et al., 2003; Verloes
et al., 2006; Koolen et al., 2008; Beysen et al., 2009]. Evaluation of
patients with BPES-like phenotypes or BMR spectrum should
include array CGH because the distinctions between BMR types
isnot always clear. Recentwork in thefieldofOhdo syndrome/BMR
syndromes showedmutations inKAT6B, a histone acetyltransferase
encoded on chromosome 10q22, in the Say–Barber–Biesecker
variant of Ohdo syndrome [Clayton-Smith et al., 2011]. Future
work will help to define whether genes in the 1q21.3q23.3 interval
reported here contribute to a fraction of uncharacterized BMR
syndrome cases.
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